Skip to main content
Tiziano Barbui on Muck Rack

Tiziano Barbui

As seen in: Nature, Wiley Online Library, The Lancet, CURE Magazine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Tiziano

Contact Tiziano, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Subtype-Specific Risk of Non-Melanoma Skin Cancers in MPN Patients: An Expanded Analysis of the MPN-K Case–Control Database

|
By Tiziano Barbui, Arianna Ghirardi, A. R. Landtblom
| Wiley Online Library Verified
T.Barbui and A.Ghirardi, “Subtype-Specific Risk of Non-Melanoma Skin Cancers in MPN Patients: An Expanded Analysis of the MPN-K Case–Control Database,” American Journal of Hematology (2026): 1–4, https://doi.org/10.1002/ajh.70332. To the Editor, Patients with polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF) are known to have a two- to three-fold increased risk of developing non-melanoma skin cancer (NMSC) compared with the general population [1-3].
Open in Who Shared Issue with article?

Extending the Biological Axis Linking CHIP to Cancer Emergence

|
By Tiziano Barbui, Arianna Ghirardi, Valerio De Stefano
| Wiley Online Library Verified
To the Editor, Liu and colleagues are to be congratulated for their elegant and comprehensive study examining the prognostic impact of clonal hematopoiesis of indeterminate potential (CHIP) identified before the development of cancer [1]. Using the UK Biobank resource, they analyzed a prospective cohort of 63 486 individuals who later developed incident cancers between 2006 and 2022, of whom 2860 (4.5%) carried CHIP prior to cancer diagnosis.
Open in Who Shared Issue with article?

A Clinically Applicable Model Using Blood Counts to Support the Diagnosis of Prefibrotic Myelofibrosis Versus Essential Thrombocythemia

|
By Tiziano Barbui, Jürgen Thiele, Arianna Ghirardi, Hans Michael Kvasnicka
| Wiley Online Library Verified
Conflicts of Interest The authors declare no conflicts of interest. References 1 E. S. Jaffe, N. L. Harris, H. Stein, and J. W. Vardiman, eds., WHO Classification of Tumours: Tumours of Haematopoietic and Lymphoid Tissues (IARC Press, 2001). 2, , , et al., WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. (International Agency for Research on Cancer, 2008).
Open in Who Shared Issue with article?
See all 19 licensed articles (21 Total)